| Teva Pharma AG - Letrozol-Teva 2,5 mg, Filmtabletten | | 60394 | | 01 | | Letrozol-Teva 2,5 mg | | Filmtabletten | | L02BG04 | | Letrozol | | 28.03.2011 | | |
| | Composition | | letrozolum 2.5 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, lactosum monohydricum 63.6 mg, silica colloidalis anhydrica, carboxymethylamylum natricum A corresp. natrium 0.29 mg, Überzug: macrogolum 3350, talcum, poly(alcohol vinylicus), E 102 0.02 mg, E 132, E 171, E 172 (flavum) pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Letrozol | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Letrozol | 2.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) pro Compresso Obducto | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 102 | 0.02 mg | color. | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Lactose Monohydrate | 63.6 mg | | | Macrogol | 3350 | Überzug | | Magnesii Stearas | | | | Maydis Amylum | | | | Poly(Alcohol Vinylicus) | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 Comprimé(s) | 53.30 | 74.40 | B | LS | Non | | 002 | 100 Comprimé(s) | 176.81 | 208.75 | B | LS | Non |
|
|
